[Cloning and expression of human TNFR (P55)-IgG Fc fusion protein in eukaryotic cells].

Xu C , Zhang Z , An N
Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology 15 ( 2) 116

2001
Abstract PO062: Isolation of tumor-infiltrating lymphocytes for higher sensitivity gene expression profiling

Jacques Moisan , Sireesha Yalavarthi , Bartholomew Naughton , Clotilde Bourin
Cancer immunology research 9

2021
NSCLC Driven by DDR2 Mutation is Sensitive to Dasatinib and JQ1 Combination Therapy

Chunxiao Xu , Kevin A. Buczkowski , Yanxi Zhang , Hajime Asahina
Molecular Cancer Therapeutics 14 ( 10) 2382 -2389

35
2015
The insertion domain of the duck hepatitis B virus core protein plays a role in nucleocapsid assembly.

Haitao Guo , Carol E. Aldrich , Jeffry Saputelli , Chunxiao Xu
Virology 353 ( 2) 443 -450

13
2006
993
2004
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

Zhao Chen , Katherine Cheng , Zandra Walton , Yuchuan Wang
Nature 483 ( 7391) 613 -617

362
2012
Inhibition of ALK, PI3K/MEK and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene

Zhao Chen , Takaaki Sasaki , Xiaohong Tan , Julian Carretero
Cancer Research 70 ( 23) 9827 -9836

220
2010
STING Agonists Induce an Innate Antiviral Immune Response against Hepatitis B Virus

Fang Guo , Yanxing Han , Xuesen Zhao , Jianghua Wang
Antimicrobial Agents and Chemotherapy 59 ( 2) 1273 -1281

127
2015
Acquired Resistance to Dasatinib in Lung Cancer Cell Lines Conferred by DDR2 Gatekeeper Mutation and NF1 Loss

Ellen M. Beauchamp , Brittany A. Woods , Austin M. Dulak , Li Tan
Molecular Cancer Therapeutics 13 ( 2) 475 -482

37
2014
34
2009
Correction to: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018).

Sneha Berry , Nicolas Giraldo , Peter Nguyen , Benjamin Green
Journal for ImmunoTherapy of Cancer 7 ( 1) 46

4
2019
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

Peter S. Hammerman , Martin L. Sos , Alex H. Ramos , Chunxiao Xu
Cancer Discovery 1 ( 1) 78 -89

414
2011
Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors

Dalia Ercan , Chunxiao Xu , Masahiko Yanagita , Calixte S. Monast
Cancer Discovery 2 ( 10) 934 -947

202
2012
Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

Yan Liu , Kevin Marks , Glenn S. Cowley , Julian Carretero
Cancer Discovery 3 ( 8) 870 -879

89
2013
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR mutant Lung Cancer

Erin M. Tricker , Chunxiao Xu , Sharmeen Uddin , Marzia Capelletti
Cancer Discovery 5 ( 9) 960 -971

132
2015
Alpha-Interferon Suppresses Hepadnavirus Transcription by Altering Epigenetic Modification of cccDNA Minichromosomes

Fei Liu , Matthew Campagna , Yonghe Qi , Xuesen Zhao
PLoS Pathogens 9 ( 9) e1003613

109
2013
Identification of oncogenic and drug-sensitizing mutations in the extracellular domain of FGFR2

Junko Tanizaki , Dalia Ercan , Marzia Capelletti , Michael Dodge
Cancer Research 75 ( 15) 3139 -3146

21
2015
Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.

Margaret Soucheray , Marzia Capelletti , Inés Pulido , Yanan Kuang
Cancer Research 75 ( 20) 4372 -4383

67
2015